Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial Academic Article Article uri icon

Overview

MeSH Major

  • Anti-Infective Agents, Local
  • Facial Paralysis
  • Hearing Loss, Sensorineural
  • Silver Nitrate
  • Tympanic Membrane Perforation
  • Tympanoplasty

abstract

  • Bristol-Myers Squibb.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(15)70122-1

PubMed ID

  • 25840693

Additional Document Info

start page

  • 522

end page

  • 30

volume

  • 16

number

  • 5